New Generation Treatments Are Now on the World Stage; Global Move from the Turkish Biotechnology Company that made a name for itself with Signal Therapy

AVB Biotechnology Founder and Chairman of the Board Serkan Tunç said they are happy to implement the signal therapy system used with the quantum tunneling technique (invented in 2020) in health, and said that many diseases that have not yet been implemented in approximately 1 billion people and that cannot be cured can now be treated in animals.

Tunç said, “As AVB Biotechnology, we have carried out record-breaking many successful scientific studies on deadly diseases with no cure, and we continue to do so. As a Turkish company, we believe that we have made our voice heard in the national arena, and with this belief, we now take our place in global markets with our Vetbiotech Biotechnology company, a subsidiary of AVB Biotechnology.”

Explaining which diseases will be treated in animals, Serkan Tunç said, “In addition to the treatments of infections caused by bacteria and fungi, especially all virus types, sepsis, stroke, paralysis and inflammatory diseases such as Myelitis, Encephalitis, Nephritis, and Pancreatitis, which have not yet been treated in humans, hydrocephalus, clot and edema treatments in the brain can be done without surgery. In short, we are realizing treatments that cannot be done by spending millions of dollars.”

“LIVESTOCK INDUSTRY HAS MORE THAN $2 TRILLION VOLUME”

"Animal treatments reach an increasing cost as the size associated with humans increases," said Tunç and continued “The cost of newborn calf deaths due to sepsis alone is around 50 billion dollars annually. The effect of our treatment technology on highly lethal sepsis has been proven to be 100 percent and we have proven it with scientific studies. This treatment technology we have developed is equipped to minimize losses not only in farm animals but also in pet animals. We are a highly competitive company and we have no doubt that we will have a voice in the world thanks to this technology we have developed.”

“HEALTHY ANIMALS ARE THE FOUNDATION OF A HEALTHY SOCIETY”

 Stressed the importance of animal breeding, especially for meat and milk production, in terms of public health, Tunç said, “Due to the drugs used in farm animals, resistance has developed in bacteria in recent years and this effect has begun to be seen clearly in humans. Thanks to the treatment we have developed and the technology that forms its infrastructure, there is no need for the use of any drugs and chemicals in animal health. Thus, antibiotic-free meat and milk production are possible. As our treatments become more widespread, the notion of resistant bacteria will gradually disappear in terms of the health of the populations," continued as follows:

“In addition to this situation, some viruses are likely to be transmitted from animals to humans and can threaten public health. Also, mass animal cullings are also carried out. Thanks to the treatment technology we have developed, such negative situations will not occur again in the near future. Because we are talking about superior technology, can affect not only a single type of virus, but also all its mutations and destroy it in the body.”

 “REAL-TIME TREATMENT FOLLOW-UP SYSTEM”

Underlining the treatment products are subject to a high-quality management system and the obligation to be followed, Tunç said, “Unfortunately, the follow-up of the treatment products is done in a way that is not transparent enough. We have raised existing standards and turned them into a real-time product and patient treatment tracking system. Since Dr Biolyse ® is an artificial intelligence device, it has the advantage of being controlled all over the world via a cloud. It offers the opportunity to see simultaneously what kind of treatment is done in the world, who do these treatments, and which patient and disease are applied. Thus, our technology and treatments will be monitored instantly all over the world in a transparent manner. With this system, we have created the world's largest scientific data source. We are proud of being the first company in the world to implement this practice."